Interferon beta gene therapy (Biogen Idec/Targeted Genetics)

N/A

Report date: 2023/10/26 16:56:43

Base Information

Drug NameInterferon beta gene therapy (Biogen Idec/Targeted Genetics)
Drug Alias NameBeta-interferon gene therapy-Biogen Idec/Targeted GeneticsIDEC 201IDEC-201Ad-beta-IfnBG-00001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasm MetastasisColorectal NeoplasmsMesothelioma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiogen IncTargeted Genetics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogen IncNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisColorectal NeoplasmsMesothelioma +[7] 

Other Information

ATC CodeN/A
Related LinksN/A